Microalbuminuria Increases CAC Risk

NEW ORLEANS—Microalbuminuria increases both the odds of developing coronary artery calcification (CAC) in patients without symptoms of coronary heart disease and the likelihood of CAC progression, Andrew P. DeFilippis, MD, MSc, reported here at the 2008 Scientific Sessions of the American Heart Association.

U.K. Team: GFR Estimates Important

SAN FRANCISCO—British researchers have endorsed U.S. guidelines stating that screening diabetic patients for renal disease should involve estimated glomerular filtration rate (eGFR) in addition to testing for albuminuria.

Target Microalbuminuria Aggressively

NEW ORLEANS—Microalbuminuria is a biomarker for vascular disease and warrants aggressive treatment, which may prevent progression to overt nephropathy and reduce the risk of cardiovascular events, said Debjani Mukherjee, MD, at the 23rd scientific meeting of the American Society of Hypertension.

Single Agent May Suffice To Decrease Albuminuria

Using a single drug to block the renin-angiotensin-aldosterone system (RAAS) may be just as effective as using two drugs at decreasing albuminuria in hypertensive patients with microalbuminuria and elevated cardiovascular risks, data suggest. Dual RAAS blockade achieves greater BP reductions, however.

Next post in News